UA98776C2 - СПОСОБ ДОСТАВКИ лекарственного ПРЕПАРАТА ДЛЯ УСИЛЕНИЯ СИНТЕЗА БЕЛКА В КОСТЯХ - Google Patents

СПОСОБ ДОСТАВКИ лекарственного ПРЕПАРАТА ДЛЯ УСИЛЕНИЯ СИНТЕЗА БЕЛКА В КОСТЯХ

Info

Publication number
UA98776C2
UA98776C2 UAA200904264A UAA200904264A UA98776C2 UA 98776 C2 UA98776 C2 UA 98776C2 UA A200904264 A UAA200904264 A UA A200904264A UA A200904264 A UAA200904264 A UA A200904264A UA 98776 C2 UA98776 C2 UA 98776C2
Authority
UA
Ukraine
Prior art keywords
pthrp
drug delivery
bone anabolic
analogue
increase bone
Prior art date
Application number
UAA200904264A
Other languages
English (en)
Ukrainian (uk)
Inventor
Майкл Дж. ДЕЙ
Натали Мондоли
Бенедикт Ригауд
Барт ХЕНДЕРСОН
К. Ричард Литтл
Original Assignee
Радиус Хелс, Инк.
Ипсен Фарма С.А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39430237&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA98776(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Радиус Хелс, Инк., Ипсен Фарма С.А.С. filed Critical Радиус Хелс, Инк.
Publication of UA98776C2 publication Critical patent/UA98776C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Изобретение касается стабильной при хранении композиции, которая содержит аналог белка, связанного с гормоном паращитовидной железы (PTHrP), а также способов применения аналога PTHrP и предложенных композиций на основе PTHrP в лечении остеопороза, для увеличения костной массы или для улучшения качества костной ткани.
UAA200904264A 2006-10-03 2007-10-03 СПОСОБ ДОСТАВКИ лекарственного ПРЕПАРАТА ДЛЯ УСИЛЕНИЯ СИНТЕЗА БЕЛКА В КОСТЯХ UA98776C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84896006P 2006-10-03 2006-10-03

Publications (1)

Publication Number Publication Date
UA98776C2 true UA98776C2 (ru) 2012-06-25

Family

ID=39430237

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200904264A UA98776C2 (ru) 2006-10-03 2007-10-03 СПОСОБ ДОСТАВКИ лекарственного ПРЕПАРАТА ДЛЯ УСИЛЕНИЯ СИНТЕЗА БЕЛКА В КОСТЯХ

Country Status (28)

Country Link
US (1) US8148333B2 (ru)
EP (2) EP2073789B8 (ru)
JP (1) JP5375611B2 (ru)
KR (4) KR101512377B1 (ru)
CN (2) CN102274492B (ru)
AU (1) AU2007322334B2 (ru)
BR (2) BRPI0719821B8 (ru)
CA (1) CA2664734C (ru)
CY (1) CY1119198T1 (ru)
DK (2) DK2957278T3 (ru)
ES (2) ES2637283T3 (ru)
FR (1) FR23C1024I1 (ru)
HK (1) HK1214181A1 (ru)
HR (1) HRP20171217T1 (ru)
IL (1) IL197926A (ru)
LT (1) LT2957278T (ru)
MX (1) MX2009003569A (ru)
NL (1) NL301235I2 (ru)
NO (1) NO344885B1 (ru)
NZ (1) NZ576682A (ru)
PL (1) PL2957278T3 (ru)
PT (2) PT2957278T (ru)
RS (1) RS56164B1 (ru)
RU (1) RU2506070C2 (ru)
SG (1) SG175580A1 (ru)
SI (1) SI2957278T1 (ru)
UA (1) UA98776C2 (ru)
WO (1) WO2008063279A2 (ru)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803770B2 (en) 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
ES2637283T3 (es) 2006-10-03 2017-10-11 Radius Health, Inc. Una composición estable que comprende PTHrP y usos de la misma
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
PT2568806T (pt) 2010-05-12 2016-08-05 Radius Health Inc Regimes terapêuticos
WO2012047617A1 (en) 2010-09-28 2012-04-12 Radius Health, Inc. Selective androgen receptor modulators
EP2472328B1 (en) 2010-12-31 2013-06-19 Rohm and Haas Electronic Materials LLC Coating compositions for use with an overcoated photoresist
EP2472329B1 (en) 2010-12-31 2013-06-05 Rohm and Haas Electronic Materials LLC Coating compositions for use with an overcoated photoresist
CA2833571A1 (en) 2011-04-22 2012-10-26 Radius Health, Inc. Method of drug delivery for pth, pthrp and related peptides
CN103561757B (zh) * 2011-06-07 2016-01-06 旭化成制药株式会社 高纯度含pth冷冻干燥制剂及其制造方法
CN104080441B (zh) 2011-11-30 2020-02-28 3M创新有限公司 包括肽治疗剂和氨基酸的微针装置、制备和使用其的方法
CN113288887A (zh) 2015-04-29 2021-08-24 雷迪厄斯制药公司 用于治疗癌症的方法
CN108025042A (zh) * 2015-07-06 2018-05-11 董正欣 PTHrP类似物的新型制剂
KR101982103B1 (ko) 2015-08-31 2019-05-27 롬 앤드 하스 일렉트로닉 머트어리얼즈 엘엘씨 오버코팅된 포토레지스트와 함께 사용하기 위한 코팅 조성물
BR112018007159A2 (pt) * 2015-10-09 2018-11-06 3M Innovative Properties Co formulações de análogos de pthrp, emplastros transdérmicos dos mesmos e usos dos mesmos
EP3481414B1 (en) 2016-04-18 2021-11-03 Radius Health, Inc. Formulations of abaloparatide, transdermal patches thereof, and uses thereof
EP4066827A1 (en) 2016-06-22 2022-10-05 Ellipses Pharma Ltd Ar+ breast cancer treatment methods
CN110114065A (zh) * 2016-11-30 2019-08-09 珀杜研究基金会 通过甲状旁腺激素受体刺激进行的骨折靶向性骨再生
EP3565542B1 (en) 2017-01-05 2024-04-10 Radius Pharmaceuticals, Inc. Polymorphic forms of rad1901-2hcl
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
EP3765488A1 (en) * 2018-03-12 2021-01-20 Fresenius Kabi iPSUM S.r.l. Process for the manufacture of pthrp analogue
AU2019297421A1 (en) 2018-07-04 2021-01-28 Radius Pharmaceuticals, Inc. Polymorphic forms of RAD 1901-2HCL
EP4110371A1 (en) 2020-01-24 2023-01-04 Radius Health, Inc. Methods of stimulating bone growth with abalopartide and denosumab
WO2023281447A1 (en) 2021-07-07 2023-01-12 Radius Health, Inc. Methods of treating a cardiovascular ischemic event

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589452A (en) 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
US5821225A (en) 1992-07-14 1998-10-13 Syntex (U.S.A.) Inc. Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
US5977070A (en) 1992-07-14 1999-11-02 Piazza; Christin Teresa Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
ATE220327T1 (de) 1992-09-29 2002-07-15 Inhale Therapeutic Syst Pulmonale abgabe von aktiven fragmenten des parathormons
CN1070500C (zh) 1993-07-13 2001-09-05 森德克斯(美国)股份有限公司 甲状旁腺激素类似物和甲状旁腺激素相关肽：合成和治疗骨质疏松症的用途
US7410948B2 (en) 1995-07-13 2008-08-12 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Analogs of parathyroid hormone
US5969095A (en) 1995-07-13 1999-10-19 Biomeasure, Inc. Analogs of parathyroid hormone
US5955574A (en) 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
US5723577A (en) 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone
US6544949B1 (en) 1995-07-13 2003-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Analogs of parathyroid hormone
CN1204262A (zh) * 1995-10-17 1999-01-06 曼海姆泊灵格股份公司 稳定的含甲状旁腺激素的药物给药剂型
TW505654B (en) 1996-07-30 2002-10-11 Hoffmann La Roche Synthesis of analogs of PTH and PTHrP
US6136784A (en) 1997-01-08 2000-10-24 Amylin Pharmaceuticals, Inc. Amylin agonist pharmaceutical compositions containing insulin
AU752925B2 (en) 1997-09-09 2002-10-03 F. Hoffmann-La Roche Ag Fracture healing using PTHrP analogs
MY120063A (en) * 1997-12-09 2005-08-30 Lilly Co Eli Stabilized teriparatide solutions
US6770623B1 (en) 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
SE9801495D0 (sv) 1998-04-28 1998-04-28 Astra Ab Protein formulationa
US20050124537A1 (en) 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US7371721B2 (en) * 2000-09-18 2008-05-13 Sanos Bioscience A/S Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes
US7799757B2 (en) * 2002-06-13 2010-09-21 Michael Chorev Analogs of parathyroid hormone and PTH-related protein as bone anabolic agents
WO2004060386A1 (en) 2002-11-01 2004-07-22 Amgen, Inc. Modulators of receptors for parathyrois hormone and parathyroid hormone-related protein
TWI359026B (en) 2004-02-12 2012-03-01 Sankyo Co Pharmaceutical composition for the osteoclast rela
EP1750756A2 (en) * 2004-05-10 2007-02-14 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of parathyroid hormone
ES2637283T3 (es) 2006-10-03 2017-10-11 Radius Health, Inc. Una composición estable que comprende PTHrP y usos de la misma
US7803770B2 (en) 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog

Also Published As

Publication number Publication date
AU2007322334A1 (en) 2008-05-29
NL301235I2 (nl) 2023-08-31
KR101512377B1 (ko) 2015-04-28
KR20180117738A (ko) 2018-10-29
NZ576682A (en) 2012-08-31
BRPI0719821B1 (pt) 2020-04-14
CA2664734C (en) 2023-08-01
EP2073789A2 (en) 2009-07-01
EP2073789B1 (en) 2019-05-22
AU2007322334B2 (en) 2011-12-22
SI2957278T1 (sl) 2017-09-29
PT2957278T (pt) 2017-08-23
JP2010505835A (ja) 2010-02-25
KR20150020289A (ko) 2015-02-25
RS56164B1 (sr) 2017-11-30
CN102274492B (zh) 2014-11-26
EP2957278A1 (en) 2015-12-23
CN102274492A (zh) 2011-12-14
MX2009003569A (es) 2009-08-25
WO2008063279A9 (en) 2008-07-10
PL2957278T3 (pl) 2017-10-31
ES2637283T3 (es) 2017-10-11
KR20090083350A (ko) 2009-08-03
BRPI0719821B8 (pt) 2021-05-25
CN101578093A (zh) 2009-11-11
NO20091545L (no) 2009-05-27
BRPI0722428A2 (pt) 2013-11-26
WO2008063279A3 (en) 2009-06-25
EP2957278B1 (en) 2017-05-17
RU2506070C2 (ru) 2014-02-10
CA2664734A1 (en) 2008-05-29
CY1119198T1 (el) 2018-02-14
US20100029556A1 (en) 2010-02-04
HRP20171217T1 (hr) 2017-10-20
HK1214181A1 (zh) 2016-07-22
IL197926A0 (en) 2011-08-01
DK2073789T3 (da) 2019-08-05
SG175580A1 (en) 2011-11-28
KR20170067906A (ko) 2017-06-16
WO2008063279A2 (en) 2008-05-29
BRPI0719821A2 (pt) 2013-05-07
PT2073789T (pt) 2019-07-31
CN101578093B (zh) 2011-09-14
JP5375611B2 (ja) 2013-12-25
DK2957278T3 (en) 2017-07-31
RU2009116531A (ru) 2010-11-10
US8148333B2 (en) 2012-04-03
LT2957278T (lt) 2017-09-11
ES2739459T3 (es) 2020-01-31
EP2073789B8 (en) 2023-02-08
IL197926A (en) 2014-08-31
NO344885B1 (no) 2020-06-15
FR23C1024I1 (fr) 2023-07-21

Similar Documents

Publication Publication Date Title
UA98776C2 (ru) СПОСОБ ДОСТАВКИ лекарственного ПРЕПАРАТА ДЛЯ УСИЛЕНИЯ СИНТЕЗА БЕЛКА В КОСТЯХ
EA201190127A1 (ru) Фармацевтические составы нитазоксанида с контролируемым высвобождением
TW200633978A (en) 2,3,4,9-tetrahydro-1H-carbazole derivatives as crth2 receptor antagonists
MY143795A (en) Tetrahydropyridoindole derivatives
TW200806318A (en) Uses of anti-insulin-like growth factor I receptor antibodies
EP2392322A3 (en) Dosing regimes for trans-clomiphene
JP2014139220A5 (ru)
NZ736048A (en) The use of inhibitors of bruton’s tyrosine kinase (btk)
SG162788A1 (en) Self-buffering protein formulations
MY161593A (en) Oral formulations of cytidine analogs and methods of use thereof
MX2010002498A (es) Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol.
HK1097774A1 (en) Stable pharmaceutical composition comprising linezolid from iv
TW200638946A (en) Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
UA86441C2 (ru) (2-гидроксиэтил)триметиламмония тиоктат (холина тиоктат), имеющий гепатопротекторное, гипоаммониемическое и детоксицирующее действие, способ его получения, фармацевтическая композиция на его основе
GB2446341A (en) Method and system for transdermal drug delivery
MX2013003523A (es) Composicion farmaceutica de dosis baja.
MX2007005525A (es) Tratamiento terapeutico de resorcion ose acelerada.
WO2012044783A8 (en) Method of achieving a thymosin beta 4 concentration in a human patient
Aparicio et al. Alveolar ridge widening by distraction osteogenesis: a case report.
TW200511999A (en) Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone
WO2017007777A3 (en) NOVEL FORMULATIONS OF PTHrP ANALOGUE
Corsini et al. Effect of systemic intermittent administration of human parathyroid hormone (rhPTH [1–34]) on the resistance to reverse torque in rabbit tibiae
Levin et al. Novel implant design for initial stability of dental implants inserted in fresh extraction sockets: A preliminary study
MX2008015323A (es) Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion.
WO2007139433A8 (en) Peptide substance normalizing the metabolism in osseous and cartilaginous tissues, pharmaceutical composition on its base and the method of its application